USP25 deficiency promotes T cell dysfunction and transplant acceptance via mitochondrial dynamics
Junbo Li,Jingzeng Wang,Tianhui Pan,Xi Zhou,Huifang Yang,Lu Wang,Guobin Huang,Chen Dai,Bo Yang,Bo Zhang,Yuanyuan Zhao,Peixiang Lan,Zhishui Chen,Junbo Li,Jingzeng Wang,Tianhui Pan,Xi Zhou,Huifang Yang,Lu Wang,Guobin Huang,Chen Dai,Bo Yang,Bo Zhang,Yuanyuan Zhao,Peixiang Lan,Zhishui Chen
DOI: https://doi.org/10.1016/j.intimp.2023.109917
IF: 5.714
2023-04-01
International Immunopharmacology
Abstract:BackgroundDuring organ transplantation, pharmacologic drugs targeting T cell activation signal to inhibit T cell-mediated allo-rejection are insufficient and not durable to suppress chronic rejection. Recent advances highlight an exhausted or dysfunctional status of T cells, which favor transplant acceptance.MethodsThe models of MHC-mismatched (BALB/c to C57BL/6 or USP25 KO mice) heterotopic heart transplantation and skin transplantation were utilized to evaluate the regulatory effects of ubiquitin-specific protease 25(USP25) deficiency in vivo. The consequences of USP25 deficiency on murine T-cell proliferation, activation, cytokine secretion, mixed lymphocyte reaction (MLR) and energy metabolism were investigated in vitro. The signaling pathway of T cells in knock out mice was detected by Western blotting and Co-IP.ResultsWe found T cells were dysfunctional inUSP25KO mice. Due to T cell dysfunction, skin and heart graft had a longer survival. In these dysfunctional T cells, mitochondria number and cristae condensation were decreased. Impaired mitochondrial mass and function favored to allo-graft acceptance. Furthermore, USP25 interacted with ATP5A and ATP5B to promote their stability.ConclusionsOur data suggest that USP25 is a potential target to induce T cell dysfunction and allo-graft tolerance. And USP25 mediated mitochondrial homeostasis may contribute to reverse T cell exhaustion or dysfunction in tumor and chronic infection.
pharmacology & pharmacy,immunology